<DOC>
	<DOCNO>NCT01648855</DOCNO>
	<brief_summary>Preeclampsia complicate 2-7 % pregnancy major contributor maternal neonatal morbidity mortality worldwide . Imbalance circulate angiogenic antiangiogenic factor emerge potential key pathway pathophysiology preeclampsia . Patients preeclampsia high circulate concentration antiangiogenic factor ( ie , soluble vascular endothelial growth factor receptor-1 [ sVEGFR- 1 ] , also call soluble fms-like tyrosine kinase 1 [ sFlt1 ] ) soluble endoglin ( sEng ) ] low maternal circulating concentration free angiogenic factor ( ie , vascular endothelial growth factor [ VEGF ] placental growth factor [ PlGF ] ) patient normal pregnancy . Bronchopulmonary dysplasia main respiratory sequelae preterm birth . Its rate increase preterm infant bear mother preeclampsia . Recent study show bronchopulmonary dysplasia consistently accompany reduction number small artery abnormal distribution vessel within distal lung . This associate reduce lung VEGF expression . The main objective population-based study , ie intra uterine growth restrict preterm baby bear 30 week gestational age , examine whether level sFlt1 birth maternal umbilical cord blood amniotic fluid associate increase risk BPD .</brief_summary>
	<brief_title>Consequences Antiangiogenic Factors Involved Preeclampsia Intra-uterine Growth Restricted Preterm Newborn</brief_title>
	<detailed_description>Preeclampsia complicate 2-7 % pregnancy major contributor maternal neonatal morbidity mortality worldwide . Preeclampsia main cause intra-uterine growth restriction could lead preterm delivery fetal maternal indication . Imbalance circulate angiogenic antiangiogenic factor emerge potential key pathway pathophysiology preeclampsia . Patients preeclampsia high circulate concentration antiangiogenic factor ( ie , soluble vascular endothelial growth factor receptor-1 [ sVEGFR- 1 ] , also call soluble fms-like tyrosine kinase 1 [ sFlt1 ] ) soluble endoglin ( sEng ) ] low maternal circulating concentration free angiogenic factor ( ie , vascular endothelial growth factor [ VEGF ] placental growth factor [ PlGF ] ) patient normal pregnancy . Bronchopulmonary dysplasia main respiratory sequelae preterm birth . Its rate increase preterm infant bear mother preeclampsia . Recent study show bronchopulmonary dysplasia consistently accompany reduction number small artery abnormal distribution vessel within distal lung . This associate reduce lung VEGF expression . Infants maternal preeclampsia high cord blood sFlt-1 low PlGF VEGF circulating level . There significantly positive relationship birth weight cord blood sFlt-1 level , witness consequence antiangiogenic factor fetus . However , study date show correlation level angiogenic antiangiogenic factor main complication preterm birth . The main objective population-based study , ie 24 intra uterine growth restrict preterm baby bear 30 week gestational age mother preeclampsia , examine whether level sFlt1 birth maternal umbilical cord blood amniotic fluid associate increase risk BPD 36 week gestational age . The second objective explore link level angiogenic antiangiogenic factor main complication preterm birth , ie , necrotizing enterocolitis , intra-ventricular hemorrhage , periventricular leukomalacia infection .</detailed_description>
	<mesh_term>Premature Birth</mesh_term>
	<mesh_term>Pre-Eclampsia</mesh_term>
	<mesh_term>Bronchopulmonary Dysplasia</mesh_term>
	<mesh_term>Fetal Growth Retardation</mesh_term>
	<mesh_term>Angiogenesis Inhibitors</mesh_term>
	<criteria>Maternal preeclampsia Intra uterine growth restriction Preterm birth 30 week gestational age Congenital malformation Eutrophic fetus Chorioamnionitis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Circulating antiangiogenic factor</keyword>
	<keyword>Preeclampsia</keyword>
	<keyword>Developing lung</keyword>
	<keyword>Bronchopulmonary dysplasia</keyword>
</DOC>